Brain Stimulation + Behavioral Training for Peripheral Nerve Injury
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores a new method to aid recovery from peripheral nerve injuries, such as those from hand transplants or severe hand injuries. It combines special exercises with a gentle brain stimulation technique called transcranial direct current stimulation (tDCS) to determine if it can enhance hand function. This approach includes Modified Constraint Induced Movement Therapy, which involves specific exercises to improve movement. Individuals who have undergone hand transplants, reattachments, or nerve repairs and continue to experience difficulties in regaining normal hand function may be suitable candidates, particularly if about a year has passed since their surgery. As an unphased trial, this study provides a unique opportunity to investigate innovative recovery methods.
Do I need to stop my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that this technique is safe for improving functional recovery in peripheral nerve injuries?
Research has shown that Modified Constraint Induced Movement Therapy (CIMT) is generally safe. This therapy involves using the affected limb more while limiting the use of the other limb, and studies have found it can improve movement without causing major side effects.
Transcranial Direct Current Stimulation (tDCS) is also considered safe. Reviews indicate that tDCS, a non-invasive method of stimulating the brain, does not cause serious side effects. It can help the brain reorganize without damaging brain tissue.
Both CIMT and tDCS have strong safety records. They are well-tolerated and can aid in motor recovery without major safety concerns.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it explores the potential of combining bi-hemispheric transcranial direct current stimulation (tDCS) with modified Constraint Induced Movement Therapy (CIMT) to improve hand function in patients with chronic peripheral nerve injuries and those who have undergone hand transplantation or replantation. Unlike traditional therapies that primarily focus on physical rehabilitation, this approach uses tDCS to stimulate both hemispheres of the brain, potentially enhancing neural plasticity and recovery. By integrating this brain stimulation technique with CIMT, which encourages the use of the affected limb, the trial aims to determine if this dual approach can break through recovery plateaus seen in conventional treatments.
What evidence suggests that this trial's treatments could be effective for peripheral nerve injury?
This trial will evaluate the combination of modified Constraint Induced Movement Therapy (CIMT) with transcranial direct current stimulation (tDCS) to improve hand and arm function in patients with peripheral nerve injuries and those who have undergone hand transplantation or replantation. Studies have shown that modified CIMT aids individuals recovering from strokes and other brain injuries by encouraging movement of the weaker hand while limiting the use of the stronger one. Research indicates that adding tDCS, which gently stimulates the brain, to rehabilitation exercises can further enhance hand recovery. Together, these treatments aim to help the brain adapt and improve recovery for those with nerve injuries or after hand transplants. Early findings suggest these methods can make everyday arm and hand activities easier.46789
Who Is on the Research Team?
Scott H Frey, Ph.D., Ed.M.
Principal Investigator
University of Missouri-Columbia
Are You a Good Fit for This Trial?
This trial is for people who've had certain hand surgeries like transplants or nerve repairs and are in the later stages of recovery (about a year to a year and a half post-surgery). It's not for those with severe brain injuries, serious mental health issues, chronic neurological conditions, pregnancy, seizure history, or specific implants.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive bi-hemispheric transcranial direct current stimulation (tDCS) combined with modified Constraint Induced Movement Therapy (CIMT) to enhance functional recovery
Follow-up
Participants are monitored for changes in upper limb movement and function using actigraphy and functional tests
What Are the Treatments Tested in This Trial?
Interventions
- Modified Constraint Induced Movement Therapy
- Transcranial Direct Current Stimulation
Modified Constraint Induced Movement Therapy is already approved in United States, European Union for the following indications:
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Missouri-Columbia
Lead Sponsor
Christine M. Kleinert Institute for Hand and Microsurgery
Collaborator
Washington University School of Medicine
Collaborator